NDAQ vs ORMP
Nasdaq Inc (NDAQ) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported NDAQ revenue for 2024-12-31 was $7.40B. Net income was $1.11B. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
NDAQ currently screens at market cap $51.71B and trailing P/E 40.8. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the NDAQ and ORMP stock pages for the full models.
Not investment advice.